Through detecting the cytokines levels using ELISA analysis, we found that, compared to the control group, the mExo-treated groups exhibited significantly elevated serum concentrations of cytokines TNF-α, IFN-γ, and IL-12, suggesting that mExo might enhance the innate immune response against tumor cells (Figure 7F). The gene discussed is TNF; the disease is neoplasm.